Industry Research Reports

Home > Reports > Chemical & Material > Global Nattokinase Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Nattokinase Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-07-31

Pages: 140 Pages

Report ld: 4807447

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Nattokinase Market Size(US$)

CAGR 2025-2031

10.2%

Market Size,2031

USD 67.6

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 37.7 million

Market Forecast in 2031(Value)

US$ 67.6 million

CAGR

10.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Nattokinase market is projected to grow from US$ 34.9 million in 2024 to US$ 67.6 million by 2031, at a CAGR of 10.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

A traditional Japanese food “Natto” is a food made from soybeans fermented by Bacillus natto, and has been eaten since about 1,200 years ago. Enzymes that Bacillus natto produce by fermentation include protease and Dr. Oshima at Hokkaido Imperial University reported its purification and characteristics. Since then, it was investigated as a serine protease, and, in 1980s, the enzyme that degrades fibrin proteins (a cause of thrombi) was named as “Nattokinase”. Nattokinase is found in the sticky part of Natto.

Functions of Nattokinase include directly degrading a fibrin (the main component of thrombi), activating pro-urokinase (precursor for urokinase that is an thrombolytic enzyme in the body) and increasing the amount of tissue plasminogen activator (t-PA) that produces a thrombolytic enzyme, plasmin. In addition, recent research has revealed that Nattokinase has a function of degrading plasminogen activator inhibitor, PAI-1 and reducing the euglobulin lysis time, and therefore, it has a function of improving the thrombolytic activity. Furthermore, the reduction of blood pressure has also been confirmed.

China is a new production and consumption market. China's soybean product consumption and entry have always been at the forefront of the world, due to its vast market space and production raw materials and technology, the future soybean market will grow rapidly.

The aging population in the East is increasing, and thrombosis-induced heart and vascular disease is a common disease in the elderly. In the future, the city of Asia will grow quickly.

Due to heart disease, moderate wind, hypertension, hypertension, deep thrombosis (DVT), chest pain (heart pain) and other cardiovascular diseases, the prevalence of various cardiovascular diseases is increasing, leading to rapid growth in the food supplement market. Because of the busy work schedule and the ever-changing lifestyle, the global work population is unaffected by the daily needs.

Various companies are adopting various strategies to develop nattokinase, and its market prospect is expected to be broad. The fermentation of nattokinase has been extensively studied using various methods. Companies are using multiple strategies to use nattokinase in various applications.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Nattokinase market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Japan Bio Science Laboratory
Daiwa Pharmaceutical
Contek Life Science
Sungen Bioscience
Eiffel Biotech
Vedan Biotechnology

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

0-10000 Fu/g
10001-20000 Fu/g
Above 20001 Fu/g

Segment by Application

Dietary Supplement
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Nattokinase study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Nattokinase: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Nattokinase Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 0-10000 Fu/g

1.2.3 10001-20000 Fu/g

1.2.4 Above 20001 Fu/g

1.3 Market Segmentation by Application

1.3.1 Global Nattokinase Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Dietary Supplement

1.3.3 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Nattokinase Revenue Estimates and Forecasts 2020-2031

2.2 Global Nattokinase Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Nattokinase Sales Estimates and Forecasts 2020-2031

2.4 Global Nattokinase Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Nattokinase Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 China

3.4.2 China Taiwan

3.4.3 Japan

4 Competition by Manufacturers

4.1 Global Nattokinase Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Nattokinase Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 0-10000 Fu/g Market Size by Manufacturers

4.5.2 10001-20000 Fu/g Market Size by Manufacturers

4.5.3 Above 20001 Fu/g Market Size by Manufacturers

4.6 Global Nattokinase Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Nattokinase Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Nattokinase Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Nattokinase Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Nattokinase Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Nattokinase Sales and Revenue by Type (2020-2031)

7.4 North America Nattokinase Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Nattokinase Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Nattokinase Sales and Revenue by Type (2020-2031)

8.4 Europe Nattokinase Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Nattokinase Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Nattokinase Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Nattokinase Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Nattokinase Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Nattokinase Sales and Revenue by Type (2020-2031)

10.4 Central and South America Nattokinase Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Nattokinase Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Nattokinase Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Nattokinase Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Nattokinase Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Japan Bio Science Laboratory

12.1.1 Japan Bio Science Laboratory Corporation Information

12.1.2 Japan Bio Science Laboratory Business Overview

12.1.3 Japan Bio Science Laboratory Nattokinase Product Models, Descriptions and Specifications

12.1.4 Japan Bio Science Laboratory Nattokinase Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Japan Bio Science Laboratory Nattokinase Sales by Product in 2024

12.1.6 Japan Bio Science Laboratory Nattokinase Sales by Application in 2024

12.1.7 Japan Bio Science Laboratory Nattokinase Sales by Geographic Area in 2024

12.1.8 Japan Bio Science Laboratory Nattokinase SWOT Analysis

12.1.9 Japan Bio Science Laboratory Recent Developments

12.2 Daiwa Pharmaceutical

12.2.1 Daiwa Pharmaceutical Corporation Information

12.2.2 Daiwa Pharmaceutical Business Overview

12.2.3 Daiwa Pharmaceutical Nattokinase Product Models, Descriptions and Specifications

12.2.4 Daiwa Pharmaceutical Nattokinase Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Daiwa Pharmaceutical Nattokinase Sales by Product in 2024

12.2.6 Daiwa Pharmaceutical Nattokinase Sales by Application in 2024

12.2.7 Daiwa Pharmaceutical Nattokinase Sales by Geographic Area in 2024

12.2.8 Daiwa Pharmaceutical Nattokinase SWOT Analysis

12.2.9 Daiwa Pharmaceutical Recent Developments

12.3 Contek Life Science

12.3.1 Contek Life Science Corporation Information

12.3.2 Contek Life Science Business Overview

12.3.3 Contek Life Science Nattokinase Product Models, Descriptions and Specifications

12.3.4 Contek Life Science Nattokinase Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Contek Life Science Nattokinase Sales by Product in 2024

12.3.6 Contek Life Science Nattokinase Sales by Application in 2024

12.3.7 Contek Life Science Nattokinase Sales by Geographic Area in 2024

12.3.8 Contek Life Science Nattokinase SWOT Analysis

12.3.9 Contek Life Science Recent Developments

12.4 Sungen Bioscience

12.4.1 Sungen Bioscience Corporation Information

12.4.2 Sungen Bioscience Business Overview

12.4.3 Sungen Bioscience Nattokinase Product Models, Descriptions and Specifications

12.4.4 Sungen Bioscience Nattokinase Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Sungen Bioscience Nattokinase Sales by Product in 2024

12.4.6 Sungen Bioscience Nattokinase Sales by Application in 2024

12.4.7 Sungen Bioscience Nattokinase Sales by Geographic Area in 2024

12.4.8 Sungen Bioscience Nattokinase SWOT Analysis

12.4.9 Sungen Bioscience Recent Developments

12.5 Eiffel Biotech

12.5.1 Eiffel Biotech Corporation Information

12.5.2 Eiffel Biotech Business Overview

12.5.3 Eiffel Biotech Nattokinase Product Models, Descriptions and Specifications

12.5.4 Eiffel Biotech Nattokinase Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Eiffel Biotech Nattokinase Sales by Product in 2024

12.5.6 Eiffel Biotech Nattokinase Sales by Application in 2024

12.5.7 Eiffel Biotech Nattokinase Sales by Geographic Area in 2024

12.5.8 Eiffel Biotech Nattokinase SWOT Analysis

12.5.9 Eiffel Biotech Recent Developments

12.6 Vedan Biotechnology

12.6.1 Vedan Biotechnology Corporation Information

12.6.2 Vedan Biotechnology Business Overview

12.6.3 Vedan Biotechnology Nattokinase Product Models, Descriptions and Specifications

12.6.4 Vedan Biotechnology Nattokinase Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Vedan Biotechnology Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Nattokinase Industry Chain

13.2 Nattokinase Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Nattokinase Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Nattokinase Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Nattokinase Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Nattokinase Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Nattokinase Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Nattokinase Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Nattokinase Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Nattokinase Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Nattokinase Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Nattokinase Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global Nattokinase Sales by Region (2020-2025) & (Tons)

Table 8. Global Nattokinase Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Nattokinase Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global Nattokinase Production by Region (2020-2025) & (Tons)

Table 12. Global Nattokinase Production by Region (2026-2031) & (Tons)

Table 13. Global Nattokinase Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global Nattokinase Sales Share by Manufacturers (2020-2025)

Table 15. Global Nattokinase Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Nattokinase Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Nattokinase by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nattokinase as of 2024)

Table 19. Global Nattokinase Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Nattokinase Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers Nattokinase Manufacturing Base and Headquarters

Table 22. Global Nattokinase Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Nattokinase Sales by Type (2020-2025) & (Tons)

Table 26. Global Nattokinase Sales by Type (2026-2031) & (Tons)

Table 27. Global Nattokinase Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Nattokinase Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Nattokinase ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Nattokinase Sales by Application (2020-2025) & (Tons)

Table 32. Global Nattokinase Sales by Application (2026-2031) & (Tons)

Table 33. Nattokinase High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Nattokinase Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Nattokinase Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Nattokinase ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Nattokinase Growth Accelerators and Market Barriers

Table 40. North America Nattokinase Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Nattokinase Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Nattokinase Growth Accelerators and Market Barriers

Table 43. Europe Nattokinase Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Nattokinase Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Nattokinase Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Nattokinase Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Nattokinase Growth Accelerators and Market Barriers

Table 48. Southeast Asia Nattokinase Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Nattokinase Investment Opportunities and Key Challenges

Table 50. Central and South America Nattokinase Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Nattokinase Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Nattokinase Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Japan Bio Science Laboratory Corporation Information

Table 54. Japan Bio Science Laboratory Description and Major Businesses

Table 55. Japan Bio Science Laboratory Product Models, Descriptions and Specifications

Table 56. Japan Bio Science Laboratory Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Japan Bio Science Laboratory Sales Value Proportion by Product in 2024

Table 58. Japan Bio Science Laboratory Sales Value Proportion by Application in 2024

Table 59. Japan Bio Science Laboratory Sales Value Proportion by Geographic Area in 2024

Table 60. Japan Bio Science Laboratory Nattokinase SWOT Analysis

Table 61. Japan Bio Science Laboratory Recent Developments

Table 62. Daiwa Pharmaceutical Corporation Information

Table 63. Daiwa Pharmaceutical Description and Major Businesses

Table 64. Daiwa Pharmaceutical Product Models, Descriptions and Specifications

Table 65. Daiwa Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Daiwa Pharmaceutical Sales Value Proportion by Product in 2024

Table 67. Daiwa Pharmaceutical Sales Value Proportion by Application in 2024

Table 68. Daiwa Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 69. Daiwa Pharmaceutical Nattokinase SWOT Analysis

Table 70. Daiwa Pharmaceutical Recent Developments

Table 71. Contek Life Science Corporation Information

Table 72. Contek Life Science Description and Major Businesses

Table 73. Contek Life Science Product Models, Descriptions and Specifications

Table 74. Contek Life Science Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Contek Life Science Sales Value Proportion by Product in 2024

Table 76. Contek Life Science Sales Value Proportion by Application in 2024

Table 77. Contek Life Science Sales Value Proportion by Geographic Area in 2024

Table 78. Contek Life Science Nattokinase SWOT Analysis

Table 79. Contek Life Science Recent Developments

Table 80. Sungen Bioscience Corporation Information

Table 81. Sungen Bioscience Description and Major Businesses

Table 82. Sungen Bioscience Product Models, Descriptions and Specifications

Table 83. Sungen Bioscience Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Sungen Bioscience Sales Value Proportion by Product in 2024

Table 85. Sungen Bioscience Sales Value Proportion by Application in 2024

Table 86. Sungen Bioscience Sales Value Proportion by Geographic Area in 2024

Table 87. Sungen Bioscience Nattokinase SWOT Analysis

Table 88. Sungen Bioscience Recent Developments

Table 89. Eiffel Biotech Corporation Information

Table 90. Eiffel Biotech Description and Major Businesses

Table 91. Eiffel Biotech Product Models, Descriptions and Specifications

Table 92. Eiffel Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Eiffel Biotech Sales Value Proportion by Product in 2024

Table 94. Eiffel Biotech Sales Value Proportion by Application in 2024

Table 95. Eiffel Biotech Sales Value Proportion by Geographic Area in 2024

Table 96. Eiffel Biotech Nattokinase SWOT Analysis

Table 97. Eiffel Biotech Recent Developments

Table 98. Vedan Biotechnology Corporation Information

Table 99. Vedan Biotechnology Description and Major Businesses

Table 100. Vedan Biotechnology Product Models, Descriptions and Specifications

Table 101. Vedan Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Vedan Biotechnology Recent Developments

Table 103. Key Raw Materials Distribution

Table 104. Raw Materials Key Suppliers

Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 106. Milestones in Production Technology Evolution

Table 107. Distributors List

Table 108. Market Trends and Market Evolution

Table 109. Market Drivers and Opportunities

Table 110. Market Challenges, Risks, and Restraints

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Nattokinase Product Picture

Figure 2. Global Nattokinase Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. 0-10000 Fu/g Product Picture

Figure 4. 10001-20000 Fu/g Product Picture

Figure 5. Above 20001 Fu/g Product Picture

Figure 6. Global Nattokinase Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Dietary Supplement

Figure 8. Others

Figure 9. Nattokinase Report Years Considered

Figure 10. Global Nattokinase Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 12. Global Nattokinase Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Nattokinase Revenue Market Share by Region (2020-2031)

Figure 14. Global Nattokinase Sales (2020-2031) & (Tons)

Figure 15. Global Nattokinase Sales (CAGR) by Region (2020-2031) (Tons)

Figure 16. Global Nattokinase Sales Market Share by Region (2020-2031)

Figure 17. Global Nattokinase Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 18. Global Nattokinase Production Trend by Region (2020-2031) (Tons)

Figure 19. Global Nattokinase Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Nattokinase Production Growth Rate in China (2020-2031) & (Tons)

Figure 22. Nattokinase Production Growth Rate in China Taiwan (2020-2031) & (Tons)

Figure 23. Nattokinase Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 24. Top 5 and Top 10 Manufacturers Nattokinase Sales Volume Market Share in 2024

Figure 25. Global Nattokinase Revenue Market Share Ranking (2024)

Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 27. 0-10000 Fu/g Revenue Market Share by Manufacturer in 2024

Figure 28. 10001-20000 Fu/g Revenue Market Share by Manufacturer in 2024

Figure 29. Above 20001 Fu/g Revenue Market Share by Manufacturer in 2024

Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 32. Global Nattokinase Sales Market Share by Type (2020-2031)

Figure 33. Global Nattokinase Revenue Market Share by Type (2020-2031)

Figure 34. Global Nattokinase Sales Market Share by Application (2020-2031)

Figure 35. Global Nattokinase Revenue Market Share by Application (2020-2031)

Figure 36. North America Nattokinase Sales YoY (2020-2031) & (Tons)

Figure 37. North America Nattokinase Revenue YoY (2020-2031) & (US$ Million)

Figure 38. North America Top 5 Manufacturers Nattokinase Sales Revenue (US$ Million) in 2024

Figure 39. North America Nattokinase Sales Volume (Tons) by Type (2020- 2031)

Figure 40. North America Nattokinase Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 41. North America Nattokinase Sales Volume (Tons) by Application (2020-2031)

Figure 42. North America Nattokinase Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. US Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 44. Canada Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 45. Mexico Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 46. Europe Nattokinase Sales YoY (2020-2031) & (Tons)

Figure 47. Europe Nattokinase Revenue YoY (2020-2031) & (US$ Million)

Figure 48. Europe Top 5 Manufacturers Nattokinase Sales Revenue (US$ Million) in 2024

Figure 49. Europe Nattokinase Sales Volume (Tons) by Type (2020-2031)

Figure 50. Europe Nattokinase Sales Revenue (US$ Million) by Type (2020-2031)

Figure 51. Europe Nattokinase Sales Volume (Tons) by Application (2020-2031)

Figure 52. Europe Nattokinase Sales Revenue (US$ Million) by Application (2020-2031)

Figure 53. Germany Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 54. France Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 58. Asia-Pacific Nattokinase Sales YoY (2020-2031) & (Tons)

Figure 59. Asia-Pacific Nattokinase Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Top 8 Manufacturers Nattokinase Sales Revenue (US$ Million) in 2024

Figure 61. Asia-Pacific Nattokinase Sales Volume (Tons) by Type (2020- 2031)

Figure 62. Asia-Pacific Nattokinase Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 63. Asia-Pacific Nattokinase Sales Volume (Tons) by Application (2020-2031)

Figure 64. Asia-Pacific Nattokinase Sales Revenue (US$ Million) by Application (2020-2031)

Figure 65. Indonesia Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 66. Japan Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 67. South Korea Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 68. China Taiwan Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 69. India Nattokinase Revenue (2020-2031) & (US$ Million)

Figure 70. Central and South America Nattokinase Sales YoY (2020-2031) & (Tons)

Figure 71. Central and South America Nattokinase Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Central and South America Top 5 Manufacturers Nattokinase Sales Revenue (US$ Million) in 2024

Figure 73. Central and South America Nattokinase Sales Volume (Tons) by Type (2021-2031)

Figure 74. Central and South America Nattokinase Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Central and South America Nattokinase Sales Volume (Tons) by Application (2020-2031)

Figure 76. Central and South America Nattokinase Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. Brazil Nattokinase Revenue (2020-2025) & (US$ Million)

Figure 78. Argentina Nattokinase Revenue (2020-2025) & (US$ Million)

Figure 79. Middle East, and Africa Nattokinase Sales YoY (2020-2031) & (Tons)

Figure 80. Middle East and Africa Nattokinase Revenue YoY (2020-2031) & (US$ Million)

Figure 81. Middle East and Africa Top 5 Manufacturers Nattokinase Sales Revenue (US$ Million) in 2024

Figure 82. Middle East and Africa Nattokinase Sales Volume (Tons) by Type (2021-2031)

Figure 83. South America Nattokinase Sales Revenue (US$ Million) by Type (2020-2031)

Figure 84. Middle East and Africa Nattokinase Sales Volume (Tons) by Application (2020-2031)

Figure 85. Middle East and Africa Nattokinase Sales Revenue (US$ Million) by Application (2020-2031)

Figure 86. GCC Countries Nattokinase Revenue (2020-2025) & (US$ Million)

Figure 87. Turkey Nattokinase Revenue (2020-2025) & (US$ Million)

Figure 88. Egypt Nattokinase Revenue (2020-2025) & (US$ Million)

Figure 89. South Africa Nattokinase Revenue (2020-2025) & (US$ Million)

Figure 90. Nattokinase Industry Chain Mapping

Figure 91. Regional Nattokinase Manufacturing Base Distribution (%)

Figure 92. Nattokinase Production Process

Figure 93. Regional Nattokinase Production Cost Structure

Figure 94. Channels of Distribution (Direct Vs Distribution)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Nattokinase market? zhanKai

The top companies in the global Nattokinase market are Japan Bio Science Laboratory、Daiwa Pharmaceutical、Contek Life Science.

What was the global market size of Nattokinase in 2031? shouQi

What is the annual compound growth rate of the global Nattokinase market size from 2025 to 2031? shouQi

What was the global market size of Nattokinase in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Nattokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nattokinase market size was US$ 37.66 million in 2025 and is forecast to reach a readjusted size of US$ 73.82 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 77
USD 4250.00
(Single User License)
Global Nattokinase Market Research Report 2026
The global Nattokinase market was valued at US$ 37.66 million in 2025 and is anticipated to reach US$ 73.82 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 134
USD 2900.00
(Single User License)
Nattokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nattokinase was estimated to be worth US$ 37.66 million in 2025 and is projected to reach US$ 73.82 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 95
USD 3950.00
(Single User License)
Global Nattokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nattokinase market size was US$ 34.9 million in 2024 and is forecast to a readjusted size of US$ 67.6 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 76
USD 4250.00
(Single User License)
Nattokinase - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nattokinase was estimated to be worth US$ 34.9 million in 2024 and is forecast to a readjusted size of US$ 67.6 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published Date: 2025-04-05
Pages: 101
USD 3950.00
(Single User License)
Global Nattokinase Market Insights, Forecast to 2031
The global Nattokinase market is projected to grow from US$ 37.7 million in 2025 to US$ 67.6 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Published Date: 2025-04-05
Pages: 135
USD 4900.00
(Single User License)
Global Nattokinase Market Research Report 2025
The global Nattokinase market was valued at US$ 34.92 million in 2024 and will reach US$ 67.61 million by 2031, witnessing a CAGR of 10.24% during the forecast period 2025-2031.
Published Date: 2025-03-27
Pages: 95
USD 2900.00
(Single User License)
Nattokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nattokinase was estimated to be worth US$ 35.4 million in 2024 and is forecast to a readjusted size of US$ 60.2 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 94
USD 3950.00
(Single User License)
Global Nattokinase Market Report, History and Forecast 2019-2030
The global market for Nattokinase was estimated at US$ xx million in the year 2023, is projected to reach a revised size of US$ xx million by 2030, growing at a CAGR of xx % during the forecast period 2024-2030.
Published Date: 2024-10-11
Pages: 138
USD 2300.00
(Single User License)
Global Nattokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
A traditional Japanese food “Natto” is a food made from soybeans fermented by Bacillus natto, and has been eaten since about 1,200 years ago. Enzymes that Bacillus natto produce by fermentation include protease and Dr. Oshima at Hokkaido Imperial University reported its purification and characteristics. Since then, it was investigated as a serine protease, and, in 1980s, the enzyme that degrades fibrin proteins (a cause of thrombi) was named as “Nattokinase”. Nattokinase is found in the sticky part of Natto.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)

Global Nattokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nattokinase market size was US$ 37.66 million in 2025 and is forecast to reach a readjusted size of US$ 73.82 million by 2032 with a CAGR of 10.2% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 77
USD 4250.00 (Single User License)
Global Nattokinase Market Research Report 2026
The global Nattokinase market was valued at US$ 37.66 million in 2025 and is anticipated to reach US$ 73.82 million by 2032, at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-01-05
Pages: 134
USD 2900.00 (Single User License)
Nattokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nattokinase was estimated to be worth US$ 37.66 million in 2025 and is projected to reach US$ 73.82 million, growing at a CAGR of 10.2% from 2026 to 2032.
Published: 2026-01-05
Pages: 95
USD 3950.00 (Single User License)
Global Nattokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nattokinase market size was US$ 34.9 million in 2024 and is forecast to a readjusted size of US$ 67.6 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 76
USD 4250.00 (Single User License)
Nattokinase - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nattokinase was estimated to be worth US$ 34.9 million in 2024 and is forecast to a readjusted size of US$ 67.6 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Published: 2025-04-05
Pages: 101
USD 3950.00 (Single User License)
Global Nattokinase Market Insights, Forecast to 2031
The global Nattokinase market is projected to grow from US$ 37.7 million in 2025 to US$ 67.6 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period.
Published: 2025-04-05
Pages: 135
USD 4900.00 (Single User License)
Global Nattokinase Market Research Report 2025
The global Nattokinase market was valued at US$ 34.92 million in 2024 and will reach US$ 67.61 million by 2031, witnessing a CAGR of 10.24% during the forecast period 2025-2031.
Published: 2025-03-27
Pages: 95
USD 2900.00 (Single User License)
Nattokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nattokinase was estimated to be worth US$ 35.4 million in 2024 and is forecast to a readjusted size of US$ 60.2 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 94
USD 3950.00 (Single User License)
Global Nattokinase Market Report, History and Forecast 2019-2030
The global market for Nattokinase was estimated at US$ xx million in the year 2023, is projected to reach a revised size of US$ xx million by 2030, growing at a CAGR of xx % during the forecast period 2024-2030.
Published: 2024-10-11
Pages: 138
USD 2300.00 (Single User License)
Global Nattokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
A traditional Japanese food “Natto” is a food made from soybeans fermented by Bacillus natto, and has been eaten since about 1,200 years ago. Enzymes that Bacillus natto produce by fermentation include protease and Dr. Oshima at Hokkaido Imperial University reported its purification and characteristics. Since then, it was investigated as a serine protease, and, in 1980s, the enzyme that degrades fibrin proteins (a cause of thrombi) was named as “Nattokinase”. Nattokinase is found in the sticky part of Natto.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)